Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form
Author(s) -
Vaishali Sahasrabudhe,
Kyle Matschke,
Haihong Shi,
Anne Hickman,
Angela Kong,
Barbara Rodríguez Spong,
Beverly Nickerson,
Kapildev K. Arora
Publication year - 2022
Publication title -
international journal of clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.363
H-Index - 67
ISSN - 0946-1965
DOI - 10.5414/cp204212
Subject(s) - cocrystal , bioequivalence , dosage form , amorphous solid , bioavailability , chromatography , chemistry , crossover study , pharmacology , medicine , organic chemistry , placebo , molecule , hydrogen bond , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom